Severe SARS‐CoV‐2 infection in a 32‐week pregnant woman treated with Remdesivir‐Dexamethasone combination therapy: A case report

This study shows that remdesivir and dexamethasone combination therapy can be considered as a suitable treatment choice for pregnant women infected with COVID‐19. It is worth mentioning that more studies are required to evaluate the efficacy and side effects of remdesivir monotherapy and its combina...

Descripción completa

Detalles Bibliográficos
Autores principales: Alavi, Seyed Mohammad Amin, Bahrami, Samaneh, Najafian, Mahin, Hoori, Mina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366936/
https://www.ncbi.nlm.nih.gov/pubmed/35979383
http://dx.doi.org/10.1002/ccr3.6241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366936/
https://www.ncbi.nlm.nih.gov/pubmed/35979383
http://dx.doi.org/10.1002/ccr3.6241

Ejemplares similares